CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 2,951	$ 3,730
Accounts receivable, net of allowance of $122 in 2021 and $125 in 2020	2,629	2,007
Inventories	2,453	1,916
Prepaid expenses and other current assets	839	758
Total current assets	8,872	8,411
Property, plant and equipment, net	5,178	4,722
Goodwill	9,836	3,217
Other intangible assets	7,792	1,671
Operating lease right-of-use assets	630	603
Other non-current assets	1,213	1,395
Total assets	33,521	20,019
Current liabilities:
Short-term debt	301	0
Current maturities of long-term debt and finance lease obligations	210	406
Accounts payable	1,246	1,043
Accrued expenses and other current liabilities	2,479	1,884
Total current liabilities	4,236	3,333
Long-term debt and finance lease obligations	17,149	5,786
Operating lease liabilities	522	501
Other non-current liabilities	2,493	1,673
Total liabilities	24,400	11,293
Commitments and contingencies
Equity:
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2021 and 2020	683	683
Common stock in treasury, at cost, 181,879,516 shares in 2021 and 178,580,208 shares in 2020	(11,488)	(11,051)
Additional contributed capital	6,197	6,043
Retained earnings	17,065	16,328
Accumulated other comprehensive (loss) income	(3,380)	(3,314)
Total Baxter stockholders’ equity	9,077	8,689
Noncontrolling interests	44	37
Total equity	9,121	8,726
Total liabilities and equity	$ 33,521	$ 20,019